DJIA 15,892.41 232.23 1.48%
NASDAQ 4,318.01 51.18 1.20%
S&P 500 1,854.17 25.09 1.37%
market minute promo

Gilead Sciences (NASDAQ: GILD)



company name or ticker
Company Photos
(Click to zoom)

Earnings Reaction History: Gilead Sciences Inc., 50.0% Follow-Through Indicator, 3.1% Sensitive

After-Hours Earnings Report for February 2, 2016 : GILD, EQR, YHOO, ILMN, FISV, EW, CMG, KIM, UDR,

After-Hours Earnings Report for February 2, 2016 : GILD, EQR, YHOO, ILMN, FISV, EW, CMG, KIM, UDR, CHRW, DOX, ATO

Plenty of Opportunity to Buy Individual Stocks: John Buckingham

Why Gilead Sciences Shares Tumbled 18% in January

Investors reined in exposure ahead of the launch of a competitor's drug.

Start the New Year off Right with 3 Best Biotech Stocks

2016 has been rough so far on biotech -- but owners of these three stocks need not worry.

Will Mallinckrodt (MNK) Earnings Disappoint Investors in Q1?

Can Microchip (MCHP) Keep the Earnings Streak Alive in Q3?

What to Watch Tuesday: Yahoo! to Reveal Cost-Cutting Plan

Gilead: Weighing The Chance Of A Price War

3 Biotech Stocks You Don't Have to Babysit

Are you interested in biotech stocks that don't require you to follow their every move? Our contributors think you should put these three biotech stocks on your radar.